Janus Henderson Group PLC Cogent Biosciences, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 15,773 shares of COGT stock, worth $144,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,773

Previous 15,773 -0.0%

Holding current value

$144,007

Previous $132,000 28.79%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.01 - $9.04 $12.5 Million - $18.8 Million	-2,083,584 Reduced 99.25%	15,773 $132,000
Q1 2024 May 15, 2024	BUY	$4.38 - $9.02 $9.12 Million - $18.8 Million	2,083,065 Added 12785.82%	2,099,357 $14.1 Million
Q4 2023 Feb 14, 2024	SELL	$4.06 - $10.08 $6.58 Million - $16.3 Million	-1,620,669 Reduced 99.0%	16,292 $95,000
Q3 2023 Nov 14, 2023	BUY	$9.69 - $13.34 $3.09 Million - $4.25 Million	318,849 Added 24.19%	1,636,961 $16 Million
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.24 $3.39 Million - $4.56 Million	-344,153 Reduced 20.7%	1,318,112 $15.6 Million
Q1 2023 May 15, 2023	BUY	$10.04 - $15.5 $603,082 - $931,054	60,068 Added 3.75%	1,662,265 $17.9 Million
Q4 2022 Feb 14, 2023	SELL	$10.65 - $14.84 $919,435 - $1.28 Million	-86,332 Reduced 5.11%	1,602,197 $18.5 Million
Q3 2022 Nov 14, 2022	SELL	$9.39 - $16.99 $4.15 Million - $7.51 Million	-441,967 Reduced 20.74%	1,688,529 $25.2 Million
Q2 2022 Aug 15, 2022	SELL	$3.92 - $9.73 $4.06 Million - $10.1 Million	-1,034,745 Reduced 32.69%	2,130,496 $19.2 Million
Q1 2022 May 16, 2022	BUY	$5.31 - $8.7 $3.45 Million - $5.65 Million	649,987 Added 25.84%	3,165,241 $23.7 Million
Q4 2021 Feb 14, 2022	BUY	$7.51 - $10.81 $159,910 - $230,177	21,293 Added 0.85%	2,515,254 $21.6 Million
Q3 2021 Nov 16, 2021	BUY	$5.99 - $9.14 $334,002 - $509,646	55,760 Added 2.29%	2,493,961 $21 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.3 $1.21 Million - $1.44 Million	155,073 Added 6.79%	2,438,201 $19.8 Million
Q1 2021 May 17, 2021	BUY	$7.47 - $12.34 $4.14 Million - $6.84 Million	554,458 Added 32.07%	2,283,128 $20 Million
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $15.6 Million - $22.5 Million	1,728,670 New	1,728,670 $19.4 Million

Others Institutions Holding COGT

# of Institutions

171

Shares Held

113M

Call Options Held

56.7K

Put Options Held

40.4K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $600M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Cogent Biosciences, Inc. Transaction History